Rectal neuroendocrine tumor emr resection may recur with a low chance of recurrence. Rectal neuroendocrine tumor belongs to the digestive tract endocrine tumor, the incidence rate is relatively low, and slow growth, low recurrence rate, more common is the liver and lymph node site metastasis, will invade the surrounding organs. Most of the rectal neuroendocrine tumors have no obvious symptoms in the early stage, usually found unintentionally when doing colonoscopy, but with the gradual growth of the tumor, patients may have perianal pain, abdominal pain, constipation or blood in stool, etc., and in serious cases, it may also lead to the damage of the surrounding conditions, and may also have fatigue, emaciation, urinary disorders and so on. Rectal neuroendocrine tumor, the treatment mainly includes surgical and endoscopic surgery, radiotherapy, targeted therapy and so on. It is recommended to go to the hospital in time to standardize the treatment and regular review to prevent recurrence.